Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Multivit-L
- Development stage
- Unknown
- Lead developer
- Prabha Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Multivit-L is a dietary supplement developed and marketed by Alico Pharmaceutical. It is categorized as a nutraceutical product containing the essential amino acid L-lysine in combination with various vitamins. The product is designed to address nutritional deficiencies and support overall health, growth, and immune function. L-lysine is critical for protein synthesis, tissue repair, and the production of antibodies and enzymes. As an over-the-counter supplement, it is typically used to supplement the diet in individuals with increased nutritional needs or inadequate dietary intake.
- Brand names
- Multivit-L
- Other names
- Lysine
Beyond the preview
Go deeper on Multivit-L.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Multivit-L.